MTTGPlus

Georg Thieme Verlag KG New

About this app

With the MTTGPlus app, physicians can stay informed about current treatment options for gynecological malignancies and breast cancer.

The app provides a concise overview of drug therapy options for patients with:

• early breast cancer
• metastatic breast cancer
• ovarian, cervical, or endometrial cancer

In addition, you receive evidence-based and guideline-compliant information on supportive therapy. The app offers a practical guide to managing therapy-related side effects. Topics covered include measures for patients with anemia and neutropenia, chemotherapy-induced nausea and vomiting, diarrhea, and tumor therapy-induced mucositis.

You are always up-to-date thanks to the latest guidelines and practice-relevant information.

The content of this app was created in cooperation with experts in the respective fields and Pfizer Pharma GmbH.